Healthy Clinical Trial
Official title:
Reward Circuit Modulation Via EEG-based Neurofeedback
The goal of this study is to test whether voluntary up-regulation of mesolimbic reward system activation is possible, and to examine the neurobehavioral effects of specific neuromodulation of this circuit on reward processing. This goal will be achieved by testing the effects of a novel non-invasive experimental framework for neuromodulation that relies on neurofeedback (NF), which is guided by neuronal activation in the ventral striatum (VS) and interfaced with personalized pleasurable music as feedback. We Hypothesize that it is possible to learn to volitionally regulate the VS using this musical NF approach. We further predict that successful NF training for up-regulating the VS-EFP signal will result in marked changes in neural and behavioral outcomes associated with upregulation of dopaminergic signaling.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | September 10, 2021 |
Est. primary completion date | September 10, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: Healthy without known background diseases Without known cognitive decline Have normal hearing Dominance of the right hand No history of psychiatric or neurological illnesses requiring hospitalization. The accepted criteria for inclusion for an MRI examination for medical purposes will apply, in accordance with the procedures established at the MRI Institute at the Sourasky Medical Center in Tel Aviv. Exclusion Criteria: Has a diagnosis of psychiatric or neurological diseases Uses psychiatric or neurological medications Hearing loss The accepted criteria for exclusion for an MRI examination for medical purposes will apply, according to the procedures established at the MRI Institute at the Sourasky Medical Center in Tel Aviv |
Country | Name | City | State |
---|---|---|---|
Israel | Sagol Brain Institute, Tel Aviv Sourasky Medical Center | Tel Aviv |
Lead Sponsor | Collaborator |
---|---|
Tel-Aviv Sourasky Medical Center | McGill University, Tel Aviv University |
Israel,
Frank MJ, Seeberger LC, O'reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science. 2004 Dec 10;306(5703):1940-3. Epub 2004 Nov 4. — View Citation
Mas-Herrero E, Maini L, Sescousse G, Zatorre RJ. Common and distinct neural correlates of music and food-induced pleasure: A coordinate-based meta-analysis of neuroimaging studies. Neurosci Biobehav Rev. 2021 Apr;123:61-71. doi: 10.1016/j.neubiorev.2020.12.008. Epub 2021 Jan 10. Review. — View Citation
Mas-Herrero E, Marco-Pallares J, Lorenzo-Seva U, Zatorre RJ, & Rodriguez-Fornells A 2012. Individual differences in music reward experiences. Music Perception, 31(2), 118-138.
Meir-Hasson Y, Kinreich S, Podlipsky I, Hendler T, Intrator N. An EEG Finger-Print of fMRI deep regional activation. Neuroimage. 2014 Nov 15;102 Pt 1:128-41. doi: 10.1016/j.neuroimage.2013.11.004. Epub 2013 Nov 15. Review. — View Citation
Salimpoor VN, Benovoy M, Larcher K, Dagher A, Zatorre RJ. Anatomically distinct dopamine release during anticipation and experience of peak emotion to music. Nat Neurosci. 2011 Feb;14(2):257-62. doi: 10.1038/nn.2726. Epub 2011 Jan 9. — View Citation
Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995 Jul;167(1):99-103. — View Citation
Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH. Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One. 2009 Aug 12;4(8):e6598. doi: 10.1371/journal.pone.0006598. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Reward processing (neural): mesolimbic reactivity to rewards (i.e., monetary, musical pleasure) | Measured via fMRI; application of pleasurable music listening and Monetary Incentive Delay task during fMRI scanning before and after the entire training period.
ROI analysis of the VS will be defined based on the target region used for developing the VS-EFP. Additional mesolimbic nodes will be defined based on a meta-analysis of reward. The outcome will be measured for each group, as the change (post > pre) in the contrast between reward vs control condition during the reward-related task. The investigators predict a positive change in VS response to reward following successful training among the neurofeedback group, relative to controls. Exploratory analysis: The investigators will explore the profile of change in VS activation with respect to the different stages of reward processing (i.e., reward anticipation, consumption). The investigators will further explore whether NF training resulted in a positive change in reward-related activation in additional mesolimbic nodes |
1 to 5 weeks | |
Primary | VS-EFP regulation success | Measured by change in VS-EFP power; based on the difference between EFP during 'regulate' and 'local baseline' conditions during the neurofeedback cycles. The investigators predict a greater modulation of VS-EFP power among the neurofeedback group relative to sham controls (test > sham). | 0 to 4 weeks | |
Primary | Transfer of VS-EFP regulation: VS-EFP volitional regulation success under a different context | Measured by change in VS-EFP power; based on the difference between regulate and local baseline conditions during the transfer condition; volitional regulation when no music or feedback is provided. The transfer condition is introduced at the beginning of each training session. The investigators predict a positive change in VS-EFP regulation following successful training among the neurofeedback group, relative to sham controls. | 1 to 5 weeks | |
Primary | Mesolimbic self-regulation under a different context | Measured via fMRI; a transfer task (volitional regulation when no feedback is applied) during an fMRI scan, which will take place before and after the entire training period. Region of interest (ROI) analysis of the ventral striatum (VS) will be defined based on the target region used for developing the VS-EFP. Additional regions of the mesolimbic network will be defined based on a meta-analysis of reward.
The outcome will be measured for each group, as the change (post > pre) in the contrast between 'regulate' and 'local-baseline' condition. The investigators predict a positive change in VS upregulation following successful training among the neurofeedback group, relative to sham controls. Exploratory analysis: the investigators intend to further explore whether NF training resulted in a positive change in the upregulation of additional mesolimbic nodes. |
1 to 5 weeks | |
Secondary | Reward-learning behavior | Assessed via the performance in probabilistic selection task (PST), which will be administered before and after the entire training period. This is a task of probabilistic reward learning, in which participants' ability to learn to choose a frequently rewarded symbol (e.g., symbol A which is rewarded 80% of the times) or to avoid a rarely rewarded symbol (B, 20% of the times) is examined [4].
The outcome will be measured for each group, as the change (post > pre) in the accuracy of learning from reward (select A) or from punishments (avoid B). The investigators predict a positive change in learning from rewards following successful training among the neurofeedback group, relative to sham controls. |
1 to 5 weeks | |
Secondary | Incentive motivation behavior | Measured via the performance in the Effort Expenditure for Rewards Task (Eefrt task), which will be administered before and after the entire training period. This is an effort-based decision-making task, in which participants choose to perform a 'hard' vs. 'easy' task for gaining varying amounts of monetary rewards under low/medium/high probability of reward receipt [5].
The outcome will be measured for each group, as the change (post >pre) in the proportion of choosing to expend more effort for a high/low monetary gain under high/medium/low probability. The investigators predict a positive change in the proportion of choosing the hard task for high monetary gain under lower probabilities of gaining rewards following successful training among the neurofeedback group, relative to sham controls. |
1 to 5 weeks | |
Secondary | Hedonic trait: link between hedonic traits and neurofeedback success | Measured via the Snaith Hemilton Pleasure Scale (SHAPS), a 14 item questionnaire that assesses hedonic capacity; an index of c-anhedonia will be derived as the sum of the responses [6].
The investigators predict that there will be a negative correlation between anhedonia scores following training and the performance in the NF-VS-EFP among the neurofeedback group. |
1 to 5 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |